The short answer
Keep oral magnesium at least 60 minutes after an ibandronate tablet. Ibandronate is taken first, before breakfast and other oral products, because magnesium may interfere with its absorption. There is no verified exception here for magnesium glycinate or another individual salt.
What this answer covers
Oral magnesium-containing supplements, antacids or laxatives with oral ibandronate tablets. Non-oral magnesium and ibandronate injections are outside this gut-absorption assessment.
- Supplement or preparation
- Magnesium
- Medication ingredient
- ibandronate
Why does this combination need attention?
Current prescribing information specifically lists magnesium among minerals likely to interfere with absorption. The recommendation concerns a mineral-containing product category rather than a clinical comparison of all magnesium forms. A supplement marketed as gentle, chelated or highly absorbable should not be assumed to have been tested for simultaneous use with ibandronate.
How should the doses be scheduled?
On the dosing morning, take the ibandronate tablet with a full glass of plain water while upright, before the first food, drink other than water or oral medicine. Wait at least 60 minutes before other oral products and remain upright as directed. A later meal can be a practical supplement time. Do not borrow a 30-minute rule from another osteoporosis medicine.
What should I discuss with my pharmacist?
Include occasional constipation and heartburn medicines in the review, not just daily supplements. Their magnesium can be overlooked. A pharmacist can place them later in the day while preserving the reason they are used. Painful swallowing, chest discomfort or worsening heartburn after ibandronate needs advice about possible medicine-related irritation.
What are the limits of the evidence?
The 30- versus 60-minute fasting trial supports the longer ibandronate interval but did not isolate magnesium or compare its salts. These sources do not provide a magnesium-specific loss of absorption, individual fracture risk, or a reason to avoid all dietary magnesium. The actionable conclusion is to protect the oral drug dosing window, including on a once-monthly dosing morning.
Evidence and practical considerations
Absorption & effectiveness
Keep oral magnesium at least 60 minutes after an ibandronate tablet. Ibandronate is taken first, before breakfast and other oral products, because magnesium may interfere with its absorption. There is no verified exception here for magnesium glycinate or another individual salt.
- Exact scope
- Oral magnesium-containing supplements, antacids or laxatives with oral ibandronate tablets. Non-oral magnesium and ibandronate injections are outside this gut-absorption assessment. with oral ibandronate sodium tablets
- Medication form and route
- oral ibandronate sodium tablets
- Timing or duration
- Timing applies on each prescribed oral dose day. Nutrient adequacy is an ongoing treatment consideration. Clinical trial durations and limitations are recorded in each source.
What remains uncertain
- The 30- versus 60-minute fasting trial supports the longer ibandronate interval but did not isolate magnesium or compare its salts. These sources do not provide a magnesium-specific loss of absorption, individual fracture risk, or a reason to avoid all dietary magnesium. The actionable conclusion is to protect the oral drug dosing window, including on a once-monthly dosing morning.
Factors that may matter: Medication route and release formulation; Supplement mineral content and chemical preparation; Timing relative to breakfast and other oral products.
Read the supporting source summaries
Source 1: current U.S. regulatory prescribing information
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: Patients prescribed oral ibandronate sodium tablets for postmenopausal osteoporosis.
Calcium, aluminum, magnesium and iron products are likely to interfere with absorption. Take the tablet first and wait at least 60 minutes before food, beverages other than plain water and other oral products. Supplement calcium and vitamin D if dietary intake is inadequate.
How this applies: Applies to oral magnesium-containing medicinal or supplement products under the stated medication formulation. Individual salt effects and quantitative outcome differences are not established. Exact scope: Oral magnesium-containing supplements, antacids or laxatives with oral ibandronate tablets. Non-oral magnesium and ibandronate injections are outside this gut-absorption assessment.
The label does not quantify every exact mineral or formula, prove pair-specific added toxicity, or establish the tablet absorption mechanism for intravenous use.
Source 2: peer-reviewed randomized clinical trial
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Postmenopausal women aged 55-80 with osteoporosis in a 48-week randomized open-label study; sample size not given in the inspected abstract.
Lumbar-spine BMD increased 3.07% with the 30-minute fast and 4.95% with the 60-minute fast. The shorter fast failed the prespecified non-inferiority criterion.
How this applies: Supports the oral ibandronate post-dose fasting interval; does not measure an isolated magnesium interaction or the monthly tablet effect. Exact scope: Oral magnesium-containing supplements, antacids or laxatives with oral ibandronate tablets. Non-oral magnesium and ibandronate injections are outside this gut-absorption assessment.
Breakfast timing study of a daily regimen, not a trial of an individual supplement with monthly tablets. Abstract-only access; no recommendation to increase the prescribed dose is adopted.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Current oral formulation labels, route boundaries and original dosing evidence assessed. Exact existing statements adjudicated and article prepared. Clinical sign-off not recorded. | |
| Research summary published |
Article revision: 015d2b6723b44762
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.